GGrantIndex
← Leaderboards

Kim A. Woodrow

University Of Washington

$13,186,657
Attributed
$15,410,311
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY201124
$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$15,410,311 · 8

By mechanism

R01$9,963,967 · 3
DP2$2,317,500 · 1
R33$1,594,456 · 1
R21$789,174 · 2
R56$745,214 · 1

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Pharmaceutical Preparations

Research focus

Pharmaceutical PreparationsVaginaPreventTissuesMicrobicideBiopsyDrug Delivery SystemsSimian Human Immunodeficiency VirusSafetyAids PreventionProtective EfficacyBaseCytologyFemalePreventionWomanInnovationCellsDesignHiv-1CytokineDrug KineticsDrug ResistanceProperty

Grant awards (23)

A low-profile copper intrauterine device that delivers long-acting contraception an$733,984
R01 · FY2024 · AI · contact PI
Drug-eluting fibers for on-demand and extended protection against HIV$803,529
R01 · FY2023 · AI · contact PI
A low-profile copper intrauterine device that delivers long-acting contraception an$739,742
R01 · FY2023 · AI · contact PI
Drug-eluting fibers for on-demand and extended protection against HIV$797,023
R01 · FY2022 · AI · contact PI
A low-profile copper intrauterine device that delivers long-acting contraception an$725,143
R01 · FY2022 · AI · contact PI
Drug-eluting fibers for on-demand and extended protection against HIV$782,421
R01 · FY2021 · AI · contact PI
A low-profile copper intrauterine device that delivers long-acting contraception an$754,528
R01 · FY2021 · AI · contact PI
Drug-eluting fibers for on-demand and extended protection against HIV$795,270
R01 · FY2020 · AI · contact PI
A low-profile copper intrauterine device that delivers long-acting contraception an$748,698
R01 · FY2020 · AI · contact PI
An integrated fiber-microneedle device to study and optimize immune responses$745,214
R56 · FY2020 · DE · contact PI
Drug-eluting fibers for on-demand and extended protection against HIV$778,084
R01 · FY2019 · AI · contact PI
Combination HIV prevention in drug-eluting fibers: designing for efficacy and use$650,899
R01 · FY2017 · AI · contact PI
Combination HIV prevention in drug-eluting fibers: designing for efficacy and use$567,268
R01 · FY2016 · AI · contact PI
Combination HIV prevention in drug-eluting fibers: designing for efficacy and use$560,151
R01 · FY2015 · AI · contact PI
Nanoparticle microbicides for delivery of combination antiretroviral drugs$485,734
R33 · FY2015 · AI · contact PI
Combination HIV prevention in drug-eluting fibers: designing for efficacy and use$527,227
R01 · FY2014 · AI · contact PI
Nanoparticle microbicides for delivery of combination antiretroviral drugs$444,465
R33 · FY2014 · AI · contact PI
Nanoparticle microbicides for delivery of combination antiretroviral drugs$664,257
R33 · FY2013 · AI · contact PI
A NanoGuard Vaginal Matrix as a Dual-Protection Contraceptive Microbicide$183,357
R21 · FY2013 · AI · contact PI
Nanomaterials for engineering protection in the genital mucosa$2,317,500
DP2 · FY2012 · HD · contact PI
Nanoparticle microbicides for delivery of combination antiretroviral drugs$220,503
R21 · FY2012 · AI · contact PI
A NanoGuard Vaginal Matrix as a Dual-Protection Contraceptive Microbicide$212,278
R21 · FY2012 · AI · contact PI
Nanoparticle microbicides for delivery of combination antiretroviral drugs$173,036
R21 · FY2011 · AI · contact PI